Clinical trial
TEPH: Telaglenastat Efficacy in Pulmonary Hypertension
NCT07223528
Study timeline
Study start (estimated)2026-11-01Date precision: month
Registry last updated2026-09-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Hypertensionunresolved
Interventions
TelaglenastatDRUG
Sponsors & collaborators
Chan, Stephen, MD, PhDlead sponsor
Synhale Theraputicscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07223528 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.